Alligator | Jotup

CUTENESS ALERT! Inflatable Christmas Critters for Holiday Fun

Retrieved on:

星期二, 十一月 21, 2023

Play (activity), Green sea turtle, Dino, Alligator, Working dog, Moose, Mouth, Christmas jumper, Reindeer, Walmart, Sea turtle

DALLAS, Nov. 21, 2023 /PRNewswire/ -- Decorate for Christmas with adorable critter characters from Gemmy! Walmart is your go-to shopping spot for family-friendly Christmas inflatables that kids will love. Find these fun inflatables and more in-store and online at Walmart.

Key Points:

Discover a delightful selection of Christmas Airblown® Inflatable critters from Gemmy!
Fresh off the farm, an inflatable Pink Piggy is styled with a red snout, red hooves, and curly pink tail.
Caribou and cow enthusiasts are in for a good time with the Moose in Christmas Sweater and Highland Christmas Cow .
Wearing a red Christmas sweater and green scarf, the wintry moose inflatable wears a plaid hat with fuzzy plush accents.

ALX Resources Corp. Reports Drill Results from the Alligator Lake Gold Project, SK

Retrieved on:

星期一, 六月 27, 2022

Drill hole AL22-01 successfully expanded the multiple zones of gold mineralization encountered 36 metres to the southeast in 2021 drill hole AL21-05 (see map below).

Key Points:

Drill hole AL22-01 successfully expanded the multiple zones of gold mineralization encountered 36 metres to the southeast in 2021 drill hole AL21-05 (see map below).
AL22-05 returned 0.26 g/t gold over 22.76 metres, including 1.73 g/t gold over 2.0 metres.
The granodiorite-hosted gold mineralization is also interpreted to represent the down-dip extension of a gold mineralized zone (1.93 g/t gold over 8.44 metres) encountered in drill hole AL21-05.
Forward-looking statements in this news release include: ALX's exploration results from the Company's exploration activities at the Alligator Gold Project ("Alligator"), and its plans to undertake additional exploration activities at Alligator.

ALX Resources Corp. Provides Winter Exploration Update for Saskatchewan and Ontario Projects

Retrieved on:

星期三, 二月 9, 2022

Vancouver, British Columbia--(Newsfile Corp. - February 9, 2022) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to update its shareholders on the status of its mineral exploration programs, both planned and underway, in Saskatchewan and Ontario, Canada.

Key Points:

Vancouver, British Columbia--(Newsfile Corp. - February 9, 2022) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to update its shareholders on the status of its mineral exploration programs, both planned and underway, in Saskatchewan and Ontario, Canada.
ALX commenced the 2022 exploration in mid-January 2022, projected to consist of 8 drill holes totaling approximately 1,000 metres.
Gibbons Creek is adjacent to the community of Stony Rapids, Saskatchewan, in a region hosting multiple uranium occurrences.
Forward-looking statements in this news release include: ALX's plans to undertake additional exploration activities at Alligator Lake, to initiate 2022 winter exploration at the Gibbons Creek and Electra projects, and to expend funds on those projects.

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Retrieved on:

星期二, 二月 1, 2022

LUND, Sweden, Feb. 1, 2022 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX)Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer.

Key Points:

LUND, Sweden, Feb. 1, 2022 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX)Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer.
Sumeet comes to Alligator fromMorphoSys AG, where he served as their Senior Global Program Medical Director.
Sumeet holds a Bachelor of Medicine, Bachelor of Surgery and Medical Doctorate degrees in medicine and clinical pharmacology from Seth G.S.
"We are thrilled to welcome a professional of Sumeet's caliber to the Alligator team," says Sren Bregenholt, CEO, Alligator Bioscience.

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Retrieved on:

星期二, 二月 1, 2022

LUND, Sweden, Feb. 1, 2022 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX)Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer.

Key Points:

LUND, Sweden, Feb. 1, 2022 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX)Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer.
Sumeet comes to Alligator fromMorphoSys AG, where he served as their Senior Global Program Medical Director.
Sumeet holds a Bachelor of Medicine, Bachelor of Surgery and Medical Doctorate degrees in medicine and clinical pharmacology from Seth G.S.
"We are thrilled to welcome a professional of Sumeet's caliber to the Alligator team," says Sren Bregenholt, CEO, Alligator Bioscience.

ALX Resources Corp. Begins Drilling Program at the Alligator Lake Gold Project, SK

Retrieved on:

星期三, 一月 19, 2022

Vancouver, British Columbia--(Newsfile Corp. - January 19, 2022) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce that a diamond drilling program is underway at the Alligator Lake Gold Project ("Alligator", or the "Project") located approximately 165 kilometres (103 miles) northeast of La Ronge, SK, Canada.

Key Points:

Vancouver, British Columbia--(Newsfile Corp. - January 19, 2022) - ALX Resources Corp. (TSXV: AL) (FSE: 6LLN) (OTC: ALXEF) ("ALX" or the "Company") is pleased to announce that a diamond drilling program is underway at the Alligator Lake Gold Project ("Alligator", or the "Project") located approximately 165 kilometres (103 miles) northeast of La Ronge, SK, Canada.
Alligator is the subject of an option agreement where ALX can earn up to an 80% interest in the Project (see ALX news release dated March 15, 2021 ).
The 2022 drilling program consists of up to eight (8) NQ-size diamond drill holes totaling approximately 1,000 metres.
Forward-looking statements in this news release include: the Alligator Lake Gold Project ("Alligator") is prospective for gold and base metals mineralization, the Company's plans to undertake exploration activities at Alligator, and expend funds on Alligator.

Positive Results from the Scandion Oncology and Alligator Bioscience Collaboration Further Supports Efficacy of Mitazalimab in Combination Therapy

Retrieved on:

星期四, 九月 2, 2021

CEO, Alligator, Neoplasm, Pancreatic cancer, CD40, Nasdaq, FOLFIRINOX, Goal, Pharmaceutical industry

STOCKHOLM, Sept. 2, 2021 /PRNewswire/ -- Alligator Bioscience AB (Nasdaq Stockholm: ATORX) and Scandion Oncology A/S (Nasdaq Stockholm: SCOL), today announced the conclusion of their collaboration with a very positive outcome.

Key Points:

STOCKHOLM, Sept. 2, 2021 /PRNewswire/ -- Alligator Bioscience AB (Nasdaq Stockholm: ATORX) and Scandion Oncology A/S (Nasdaq Stockholm: SCOL), today announced the conclusion of their collaboration with a very positive outcome.
The purpose of the collaboration was to explore the anti-tumor efficacy of the CD40 antibody mitazalimab in chemotherapy-resistant preclinical tumor models as an addition to chemotherapy (FOLFIRINOX) combined with SCO-101.
Both Scandion Oncology and Alligator have limited resources and our joint intention was to support the hypothesis, which now has been achieved.
The data further validate the potential of mitazalimab in combination with standard of care chemotherapy such as FOLFIRINOX.

Positive Results from the Scandion Oncology and Alligator Bioscience Collaboration Further Supports Efficacy of Mitazalimab in Combination Therapy

Retrieved on:

星期四, 九月 2, 2021

CEO, Alligator, Neoplasm, Pancreatic cancer, CD40, Nasdaq, FOLFIRINOX, Goal, Pharmaceutical industry

STOCKHOLM, Sept. 2, 2021 /PRNewswire/ -- Alligator Bioscience AB (Nasdaq Stockholm: ATORX) and Scandion Oncology A/S (Nasdaq Stockholm: SCOL), today announced the conclusion of their collaboration with a very positive outcome.

Key Points:

STOCKHOLM, Sept. 2, 2021 /PRNewswire/ -- Alligator Bioscience AB (Nasdaq Stockholm: ATORX) and Scandion Oncology A/S (Nasdaq Stockholm: SCOL), today announced the conclusion of their collaboration with a very positive outcome.
The purpose of the collaboration was to explore the anti-tumor efficacy of the CD40 antibody mitazalimab in chemotherapy-resistant preclinical tumor models as an addition to chemotherapy (FOLFIRINOX) combined with SCO-101.
Both Scandion Oncology and Alligator have limited resources and our joint intention was to support the hypothesis, which now has been achieved.
The data further validate the potential of mitazalimab in combination with standard of care chemotherapy such as FOLFIRINOX.

Alligator Bioscience Announces New Senior Director of Communications & Investor Relations

Retrieved on:

星期一, 八月 16, 2021

Communication, List of life sciences, Wall Street, CEO, Company, IR, Julie's, Alligator, CEST, CD40, Nasdaq, Nasdaq Stockholm, Public relations, Management

LUND, Sweden, Aug. 16, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that Julie Silber has joined the company as the new Senior Director of Communications and Investor Relations. Bringing over 20+ years of investor relations, strategic communications, counsel and executive financial leadership experience, Julie has served as a trusted advisor to small and medium size public companies as, both an Investor Relations Officer and as a consultant, with companies listed in the US, London, Canada, Australia, Sweden and Finland by strengthening their investor relations and shareholder communication.

Key Points:

LUND, Sweden, Aug. 16, 2021 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX)today announced that Julie Silber has joined the company as the new Senior Director of Communications and Investor Relations.
Bringing over 20+ years of investor relations, strategic communications, counsel and executive financial leadership experience, Julie has served as a trusted advisor to small and medium size public companies as, both an Investor Relations Officer and as a consultant, with companies listed in the US, London, Canada, Australia, Sweden and Finland by strengthening their investor relations and shareholder communication.
Over the last 6 years, Julie's main focus has been working with Life Sciences companies in the Nordics, most recently as Senior Director of IR at Immunovia AB.
"We are excited to welcome an executive of Julie's caliber and experience to help strengthen and expand Alligator's Communications and Investor Relations program.

Alligator Bioscience Announces New Senior Director of Communications & Investor Relations

Retrieved on:

星期一, 八月 16, 2021

Communication, List of life sciences, Wall Street, CEO, Company, IR, Julie's, Alligator, CEST, CD40, Nasdaq, Nasdaq Stockholm, Public relations, Management

LUND, Sweden, Aug. 16, 2021 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that Julie Silber has joined the company as the new Senior Director of Communications and Investor Relations. Bringing over 20+ years of investor relations, strategic communications, counsel and executive financial leadership experience, Julie has served as a trusted advisor to small and medium size public companies as, both an Investor Relations Officer and as a consultant, with companies listed in the US, London, Canada, Australia, Sweden and Finland by strengthening their investor relations and shareholder communication.

Key Points:

LUND, Sweden, Aug. 16, 2021 /PRNewswire/ --Alligator Bioscience (Nasdaq Stockholm: ATORX)today announced that Julie Silber has joined the company as the new Senior Director of Communications and Investor Relations.
Bringing over 20+ years of investor relations, strategic communications, counsel and executive financial leadership experience, Julie has served as a trusted advisor to small and medium size public companies as, both an Investor Relations Officer and as a consultant, with companies listed in the US, London, Canada, Australia, Sweden and Finland by strengthening their investor relations and shareholder communication.
Over the last 6 years, Julie's main focus has been working with Life Sciences companies in the Nordics, most recently as Senior Director of IR at Immunovia AB.
"We are excited to welcome an executive of Julie's caliber and experience to help strengthen and expand Alligator's Communications and Investor Relations program.